SYMTUZA
Analogs of SYMTUZA
Find cheaper analogs and generic equivalents for SYMTUZA.
Active Ingredient: TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE), EMTRICITABINE, DARUNAVIR (DARUNAVIR ETHANOLATE), COBICISTAT
Product Overview
About SYMTUZA
Symtuza is a prescription medication used to treat HIV-1 infection in adults. It is a fixed-dose combination of four antiretroviral drugs: tenofovir alafenamide (tenofovir alafenamide hemifumarate), emtricitabine, darunavir (darunavir ethanolate), and cobicistat.
Key Benefits & Uses
- Treatment of HIV-1 infection in adults.
- Combination therapy for HIV-1 infection, used in conjunction with other antiretroviral medications.
- Reduction of viral load and improvement of immune function in HIV-1 infected individuals.
Active Ingredient & Action
Symtuza contains four active ingredients that work together to inhibit the replication of HIV-1 virus. Tenofovir alafenamide (tenofovir alafenamide hemifumarate) is a nucleotide reverse transcriptase inhibitor (NtRTI) that inhibits the activity of reverse transcriptase, an enzyme essential for viral replication. Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) that also inhibits reverse transcriptase. Darunavir (darunavir ethanolate) is a protease inhibitor (PI) that blocks the protease enzyme, preventing the maturation of viral particles. Cobicistat is a cytochrome P450 3A (CYP3A) inhibitor that increases the plasma concentrations of darunavir and other antiretroviral medications.
Important Notes
Before taking Symtuza, inform your doctor about any medical conditions, allergies, or medications you are currently taking. Symtuza may interact with other medications, including certain antacids, and may cause side effects such as nausea, diarrhea, and headache. It is essential to follow the recommended dosage and usage instructions provided by your doctor or pharmacist.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
